BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

368 related articles for article (PubMed ID: 16320341)

  • 21. Autoimmune-associated congenital heart block: dissecting the cascade from immunologic insult to relentless fibrosis.
    Clancy RM; Buyon JP
    Anat Rec A Discov Mol Cell Evol Biol; 2004 Oct; 280(2):1027-35. PubMed ID: 15368347
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Dying right to live longer: positing apoptosis as a link between maternal autoantibodies and congenital heart block.
    Buyon JP; Clancy RM
    Lupus; 2008 Feb; 17(2):86-90. PubMed ID: 18250129
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Structurally derived mutations define congenital heart block-related epitopes within the 200-239 amino acid stretch of the Ro52 protein.
    Ottosson L; Salomonsson S; Hennig J; Sonesson SE; Dörner T; Raats J; Kuchroo VK; Sunnerhagen M; Wahren-Herlenius M
    Scand J Immunol; 2005 Feb; 61(2):109-18. PubMed ID: 15683447
    [TBL] [Abstract][Full Text] [Related]  

  • 24. More to death than dying: apoptosis in the pathogenesis of SSA/Ro-SSB/La-associated congenital heart block.
    Clancy RM; Buyon JP
    Rheum Dis Clin North Am; 2004 Aug; 30(3):589-602, x. PubMed ID: 15261343
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Opsonization of late apoptotic cells by systemic lupus erythematosus autoantibodies inhibits their uptake via an Fcgamma receptor-dependent mechanism.
    Reefman E; Horst G; Nijk MT; Limburg PC; Kallenberg CG; Bijl M
    Arthritis Rheum; 2007 Oct; 56(10):3399-411. PubMed ID: 17907194
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Specificity and effector mechanisms of autoantibodies in congenital heart block.
    Wahren-Herlenius M; Sonesson SE
    Curr Opin Immunol; 2006 Dec; 18(6):690-6. PubMed ID: 17011766
    [TBL] [Abstract][Full Text] [Related]  

  • 27. T-cell epitopes of the La/SSB autoantigen: prediction based on the homology modeling of HLA-DQ2/DQ7 with the insulin-B peptide/HLA-DQ8 complex.
    Kosmopoulou A; Vlassi M; Stavrakoudis A; Sakarellos C; Sakarellos-Daitsiotis M
    J Comput Chem; 2006 Jul; 27(9):1033-44. PubMed ID: 16639700
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Definition of a discontinuous immunodominant epitope at the NH2 terminus of the La/SS-B ribonucleoprotein autoantigen.
    McNeilage LJ; Umapathysivam K; Macmillan E; Guidolin A; Whittingham S; Gordon T
    J Clin Invest; 1992 May; 89(5):1652-6. PubMed ID: 1373741
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Anti-La/SSB antiidiotypic antibodies in maternal serum: a marker of low risk for neonatal lupus in an offspring.
    Stea EA; Routsias JG; Clancy RM; Buyon JP; Moutsopoulos HM; Tzioufas AG
    Arthritis Rheum; 2006 Jul; 54(7):2228-34. PubMed ID: 16802359
    [TBL] [Abstract][Full Text] [Related]  

  • 30. At least three distinct B cell epitopes reside in the C-terminal half of La protein, as determined by a recombinant DNA approach.
    Rauh AJ; Hornig H; Lührmann R
    Eur J Immunol; 1988 Dec; 18(12):2049-57. PubMed ID: 2464497
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Siögren's syndrome: anti-Ro and anti-La autoantibodies trigger apoptotic mechanism in the human salivary gland cell line, A-253.
    Lisi S; Sisto M; Scagliusi P; Mitolo V; D'Amore M
    Panminerva Med; 2007 Sep; 49(3):103-8. PubMed ID: 17912146
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Antibodies to Ro and La.
    Reichlin M
    Ann Med Interne (Paris); 1998 Feb; 149(1):34-41. PubMed ID: 11490515
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The value of synthetic linear epitope analogues of La/SSB for the detection of autoantibodies to La/SSB; specificity, sensitivity and comparison of methods.
    Yiannaki EE; Tzioufas AG; Bachmann M; Hantoumi J; Tsikaris V; Sakarellos-Daitsiotis M; Sakarellos C; Moutsopoulos HM
    Clin Exp Immunol; 1998 Apr; 112(1):152-8. PubMed ID: 9566804
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Idiotypes on antibodies to the La (SS-B) antigen are restricted and associated with the antigen binding site.
    Horsfall AC; Venables PJ; Mumford PA; Maini RN
    Clin Exp Immunol; 1986 Feb; 63(2):395-401. PubMed ID: 3486064
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Identification of a human-specific epitope in a conserved region of the La/SS-B autoantigen.
    Weng YM; McNeilage J; Topfer F; McCluskey J; Gordon T
    J Clin Invest; 1993 Aug; 92(2):1104-8. PubMed ID: 7688758
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Anti-La antibodies.
    St Clair EW
    Rheum Dis Clin North Am; 1992 May; 18(2):359-76. PubMed ID: 1626074
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Autoantibodies against complement C1q specifically target C1q bound on early apoptotic cells.
    Bigler C; Schaller M; Perahud I; Osthoff M; Trendelenburg M
    J Immunol; 2009 Sep; 183(5):3512-21. PubMed ID: 19648280
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Immunologic and structural studies of the lupus/Sjögren's syndrome autoantigen, La/SSB, with a monoclonal antibody.
    Harley JB; Rosario MO; Yamagata H; Fox OF; Koren E
    J Clin Invest; 1985 Aug; 76(2):801-6. PubMed ID: 2411763
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Ro52, Ro60 and La IgG autoantibody levels and Ro52 IgG subclass profiles longitudinally throughout pregnancy in congenital heart block risk pregnancies.
    Strandberg L; Salomonsson S; Bremme K; Sonesson S; Wahren-Herlenius M
    Lupus; 2006; 15(6):346-53. PubMed ID: 16830880
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Anti-Ro (SSA) and anti-La (SSB) antibodies and complete congenital heart block.
    Finkelstein Y; Adler Y; Harel L; Nussinovitch M; Youinou P
    Ann Med Interne (Paris); 1997; 148(3):205-8. PubMed ID: 9255327
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 19.